Cannabinoid agonists attenuate capsaicin-induced responses in human skin

Pain

Volumn 102, Issue 3, 2003, Pages 283-288

  Rukwied, Roman ^a   Watkinson, Allan ^a   McGlone, Francis ^a   Dvorak, Melita ^a,b  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Allodynia; Cannabinoid receptor; Capsaicin; HU210; Hyperalgesia

Indexed keywords

ALCOHOL; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; DEXANABINOL;

ADULT; ALLODYNIA; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; MALE; MECHANICAL STIMULATION; NOCICEPTION; NORMAL HUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; SKIN STIMULATION; TOUCH;

EID: 0344405669     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00401-3     Document Type: Article

References (29)

1. Bell-Krotoski J., Tomancik E. The repeatability of testing with Semmes-Weinstein monofilaments. J Hand Surg. 12:1987;155-161.
2. Calignano A., La Rana G., Giuffrida A., Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature. 394:1998;277-281.
3. Calignano A., La Rana G., Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol. 419:2001;191-198.
4. Caterina M.J., Rosen T.A., Tominaga M., Brake A.J., Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature. 398:1999;436-441.
5. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
6. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Martin B.R. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Curr Med Chem. 6:1999;721-744.
7. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA. 92:1995;3376-3380.
8. Fuentes J.A., Ruiz-Gayo M., Manzanares J., Vela G., Reche I., Corchero J. Cannabinoids as potential new analgesics. Life Sci. 65:1999;675-685.
9. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem. 232:1995;54-61.
10. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci. 17:1997;5327-5333.
11. Griffin G., Fernando S.R., Ross R.A., McKay N.G., Ashford M.L., Shire D., Huffman J.W., Yu S., Lainton J.A., Pertwee R.G. Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol. 339:1997;53-61.
12. Jancsó N., Jancsó-Gabor A., Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol. 31:1967;138-151.
13. Johanek L.M., Heitmiller D.R., Turner M., Nader N., Hodges J., Simone D.A. Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms. Pain. 93:2001;303-315.
14. Ko M.C., Woods J.H. Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. Psychopharmacology (Berl). 143:1999;322-326.
15. Koltzenburg M., Lundberg L.E., Torebjörk H.E. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain. 51:1992;207-219.
16. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.-F.P. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol. 66:1991;190-211.
17. LaMotte R.H., Lundberg L.E., Torebjörk H.E. Pain, hyperalgesia and activity in nociceptive-C units in humans after intradermal injection of capsaicin. J Physiol. 448:1992;749-764.
18. Monhemius R., Azami J., Green D.L., Roberts M.H. CB1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain. Brain Res. 908:2001;67-74.
19. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
20. Nischik M., Forster C. Analysis of skin erythema using true color images. IEEE Trans Med Imaging. 16:1997;711-716.
21. Pertwee R.G. Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors. Life Sci. 65:1999;597-605.
22. Richardson J.D., Kilo S., Hargreaves K.M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain. 75:1998;111-119.
23. Schmidt R., Schmelz M., Forster C., Ringkamp M., Torebjörk E., Handwerker H. Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci. 15:1995;333-341.
24. Smith P.B., Martin B.R. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia. Brain Res. 578:1992;8-12.
25. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., Waku K. Evidence that 2-arachidonylglycerol but not N-palmithoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. J Biol Chem. 275:2000;605-612.
26. Torebjörk H.E., Lundberg L.E., LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol. 448:1992;765-780.
27. Williamson E.M., Evans F.J. Cannabinoids in clinical practice. Drugs. 60:2000;1303-1314.
28. Ziegler E.A., Magerl W., Meyer R.A., Treede R.D. Secondary hyperalgesia to punctate mechanical stimuli - central sensitization to A-fibre nociceptor input. Brain. 122:1999;2245-2257.
29. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 400:1999;452-457.